# A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer

> **NCT05250817** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 501 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05250817
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-09
- **Primary completion:** 2023-01-04
- **Final completion:** 2023-01-04
- **Target enrollment:** 501 (ACTUAL)
- **Last updated:** 2023-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05250817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05250817, "A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05250817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*